1. Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer
   Chen-Yu Hu et al, 2019, Frontiers in Oncology CrossRef
2. A c-Met Inhibitor Suppresses Osteosarcoma Progression via the ERK1/2 Pathway in Human Osteosarcoma Cells
   Weijie Chen et al, 2021, OncoTargets and Therapy CrossRef
3. Urine proteome changes in rats subcutaneously inoculated with approximately ten tumor cells
   Jing Wei et al, 2019, PeerJ CrossRef
4. Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology
   Vishnu C. Damalanka et al, 2019, Journal of Medicinal Chemistry CrossRef
5. Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
   Yazhuo Zhang et al, 2018, Molecular Cancer CrossRef
6. High Throughput 3D Cell Migration Assay Using Micropillar/Microwell Chips
   Sang-Yun Lee et al, 2022, Molecules CrossRef
7. Inhibitors of the Growth‐Factor Activating Proteases Matriptase, Hepsin andHGFA: Strategies for Rational Drug Design and Optimization
   James W. Janetka et al, 2018, Extracellular Targeting of Cell Signaling in Cancer CrossRef
8. Circulating Levels of Omentin, Leptin, VEGF, and HGF and Their Clinical Relevance with PSA Marker in Prostate Cancer
   M. Fryczkowski et al, 2018, Disease Markers CrossRef
9. Discovery of novel conjugates of quinoline and thiazolidinone urea as potential anti-colorectal cancer agent
   Li Xiong et al, 2022, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
10. Identification of MET fusions in solid tumors: A multicenter, large scale study in China
    Wenhui Yang et al, 2023, International Journal of Cancer CrossRef
11. Evidence for 2-Methoxyestradiol-Mediated Inhibition of Receptor Tyrosine Kinase RON in the Management of Prostate Cancer
    Izhar Singh Batth et al, 2021, International Journal of Molecular Sciences CrossRef
12. The MST1R/RON Tyrosine Kinase in Cancer: Oncogenic Functions and Therapeutic Strategies
    Alex Cazes et al, 2022, Cancers CrossRef
13. Discovery of Novel, Thienopyridine-Based Tyrosine Kinase Inhibitors Targeting Tumorigenic RON Splice Variants
    Hyun Ryu et al, 2023, ACS Medicinal Chemistry Letters CrossRef
14. Identification of novel quinoline analogues bearing thiazolidinones as potent kinase inhibitors for the treatment of colorectal cancer
    Yuting Zhou et al, 2020, European Journal of Medicinal Chemistry CrossRef
15. Association between the HGF/c‑MET signaling pathway and tumorigenesis, progression and prognosis of hepatocellular carcinoma (Review)
    Wei Meng et al, 2021, Oncology Reports CrossRef
16. Recent Progress in the Development of Small Molecule c-Met Inhibitors
    Peng-Cheng Lv et al, 2019, Current Topics in Medicinal Chemistry CrossRef
17. Human telomerase reverse transcriptase promotes the epithelial to mesenchymal transition in lung cancer cells by enhancing c-MET upregulation
    Ram Raj Prasad et al, 2022, Heliyon CrossRef
18. Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges
    Pengxiao Su et al, 2023, Frontiers in Oncology CrossRef
19. Isobavachalcone inhibits the proliferation and invasion of tongue squamous cell carcinoma cells
    Yi Shi et al, 2017, Oncology Letters CrossRef
20. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition
    Zhigang Zhao et al, 2021, British Journal of Cancer CrossRef
21. Discovery of 4-((4-(4-(3-(2-(2,6-difluorophenyl)-4-oxothiazolidin-3-yl)ureido)-2-fluorophenoxy)-6-methoxyquinolin-7-yl)oxy)-N,N-diethylpiperidine-1-carboxamide as kinase inhibitor for the treatment of colorectal cancer
    Yuting Zhou et al, 2021, Bioorganic Chemistry CrossRef
22. Synthesis and preclinical evaluation of a selective MET kinase positron emission tomography tracer
    Vegard Torp Lien et al, 2023, Journal of Labelled Compounds and Radiopharmaceuticals CrossRef
23. Importance of microRNAs by mRNA-microRNA integration analysis in acute ischemic stroke patients
    Hideaki Kanki et al, 2023, Journal of Stroke and Cerebrovascular Diseases CrossRef
24. Combined targeting of EGFR and HER2 against prostate cancer stem cells
    Anna Rossini et al, 2020, Cancer Biology & Therapy CrossRef
25. Role of c-Met/HGF Axis in Altered Cancer Metabolism
    Vaishali Chandel et al, 2020, Cancer Cell Metabolism: A Potential Target for Cancer Therapy CrossRef
26. Regulation of Kinase Signaling Pathways by α6β4-Integrins and Plectin in Prostate Cancer
    Saara Koivusalo et al, 2022, Cancers CrossRef
27. Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model
    Vegard Torp Lien et al, 2021, Nuclear Medicine and Biology CrossRef